Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Sector Catalysts

CHIPS Act

Federal law funding domestic semiconductor manufacturing with grants and tax credits to reshore chip supply.

Also known as: CHIPS and Science Act, Chip Subsidies

What it is
The CHIPS and Science Act provides federal grants, loans, and an investment tax credit to expand U.S. semiconductor manufacturing and research. Commerce administers the funding awards. It aims to reduce reliance on foreign fabrication.
What it does
CHIPS awards and the manufacturing tax credit subsidize fab construction, benefiting chipmakers and their equipment and construction suppliers. Award announcements are single-name catalysts. It anchors a multi-year domestic buildout theme.
The evidence
Announced CHIPS grants to leading chipmakers have flagged multi-year fab buildouts benefiting equipment and materials suppliers.
Best for
Fabs and equipment: INTC, TSM, MU, AMAT, LRCX.
Pairs well with
export-controls, ira-tax-credits, reconciliation
Use cautiously with
Grants are milestone-based and slow; assuming award headlines equal near-term earnings overstates the timing.
Cautions
Fab payoffs are years out and depend on end-market demand cycles.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More sector catalysts

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →